Characterization of the Innate Immune Response to Crystalline Silica

对结晶二氧化硅的先天免疫反应的表征

基本信息

项目摘要

DESCRIPTION (provided by applicant): Silica is the most abundant mineral in the earth's crust account for prevalent exposure to respirable silicates in many occupations in both affluent and developing nations. Besides smoking, this is the major preventable cause of chronic obstructive pulmonary disease, with silica the causing a particularly devastating set of diseases known as pulmonary silicoses. Careful studies in both human samples and animal models have determined that crystalline forms silica (i.e., SiO2) is the cause of pulmonary inflammation that culminates in the manifestations of COPD. Moreover, these studies have implicated activation of the innate immune system, including macrophage dependent secretion of TNF and IL-1? in the pathophysiology of pulmonary silicosis. The mechanism by which crystalline silica stimulates these acute inflammatory responses remains controversial, however. Several studies have implicated members of the scavenger receptor family in promoting uptake of particulates, including crystalline silica. However, these receptors also appear to promote the uptake of noncrystalline silicates and missing signaling the motifs that would be necessary to stimulate the intracellular inflammatory responses uniquely associated with exposure to crystalline silica. Other studies have ascribed this inflammatory activity to the potential for silicate particulates to stimulate oxidant stress and promote cell death. However, these models fail to account for the unique structural features of those silica crystals that stimulate inflammation. They are further undermined by the poor correlations between oxidant stress, macrophage death and the inflammatory response exhibited by macrophages exposed to crystalline silica. Intriguingly, two pro-inflammatory crystals monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD), have recently been shown to mediate their potent biological activity through Nalp3/CIAS, a cytosolic Pattern Recognition Receptors (c-PRR). This raises the possibility that PRRs, which evolved to recognize repeating molecular patterns associated with microbes, may also recognize the repetitive pattern biologically active crystals present to the environment. Specifically, we propose to: 1. Do scavenger receptors contribute to the inflammatory response associated with crystalline silica? 2. Do PRRs from the TLR, NDB or C-type lectin receptor families direct the unique and specific inflammatory response to crystalline silica? PUBLIC HEALTH RELEVANCE The inhalation of crystalline silicates is a common occupational hazard and represents an important cause of several destructive pulmonary inflammatory diseases. However, the mechanism by which silica crystals stimulate this potent innate immune response has not been elucidated. Based on intriguing preliminary studies, we propose to investigate the role receptors from the innate immune system play in mediating the specific and destructive inflammatory response to crystalline silica.
描述(由申请人提供):二氧化硅是地壳中含量最丰富的矿物,在富裕国家和发展中国家的许多职业中,二氧化硅都普遍暴露于可吸入硅酸盐。除了吸烟,这是慢性阻塞性肺疾病的主要可预防原因,二氧化硅会导致一系列特别具有破坏性的疾病,称为肺矽肺病。在人类样品和动物模型中的仔细研究已经确定,结晶形式的二氧化硅(即,SiO2)是肺部炎症的原因,最终导致COPD的表现。此外,这些研究涉及激活先天免疫系统,包括巨噬细胞依赖分泌的TNF和IL-1?肺矽肺病的病理生理学然而,结晶二氧化硅刺激这些急性炎症反应的机制仍然存在争议。几项研究表明清道夫受体家族的成员参与促进颗粒物(包括结晶二氧化硅)的摄取。然而,这些受体似乎也促进非结晶硅酸盐的摄取,并且缺失刺激与暴露于结晶二氧化硅独特相关的细胞内炎症反应所必需的基序的信号传导。其他研究将这种炎症活性归因于硅酸盐颗粒刺激氧化应激和促进细胞死亡的潜力。然而,这些模型未能解释刺激炎症的二氧化硅晶体的独特结构特征。氧化应激、巨噬细胞死亡和暴露于结晶二氧化硅的巨噬细胞所表现出的炎症反应之间的不良相关性进一步破坏了它们。有趣的是,最近已经显示两种促炎晶体二水合焦磷酸钙(MSU)和焦磷酸钙二水合物(CPPD)通过Nalp 3/CIAS(一种细胞溶质模式识别受体(c-PRR))介导其有效的生物活性。这就提出了一种可能性,即PRRs(它进化成识别与微生物相关的重复分子模式)也可能识别存在于环境中的重复模式生物活性晶体。具体而言,我们建议:1.清道夫受体是否参与与结晶二氧化硅相关的炎症反应?2.来自TLR、NDB或C型凝集素受体家族的PRR是否指导对结晶二氧化硅的独特和特异性炎症反应? 吸入结晶硅酸盐是一种常见的职业危害,是几种破坏性肺炎性疾病的重要原因。然而,二氧化硅晶体刺激这种有效的先天免疫反应的机制尚未阐明。基于有趣的初步研究,我们建议研究先天免疫系统的受体在介导对结晶二氧化硅的特异性和破坏性炎症反应中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTIAN W SCHINDLER其他文献

CHRISTIAN W SCHINDLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTIAN W SCHINDLER', 18)}}的其他基金

Genetic characterization of the murine type I Interferon locus
小鼠 I 型干扰素基因座的遗传特征
  • 批准号:
    8780594
  • 财政年份:
    2013
  • 资助金额:
    $ 23.62万
  • 项目类别:
Genetic characterization of the murine type I Interferon locus
小鼠 I 型干扰素基因座的遗传特征
  • 批准号:
    8623890
  • 财政年份:
    2013
  • 资助金额:
    $ 23.62万
  • 项目类别:
Probing the Innate Response to 3', 5'-cyclic Diguanylate (c-diGMP)
探索对 3, 5-环二鸟苷酸 (c-diGMP) 的先天反应
  • 批准号:
    8274633
  • 财政年份:
    2011
  • 资助金额:
    $ 23.62万
  • 项目类别:
Probing the Innate Response to 3', 5'-cyclic Diguanylate (c-diGMP)
探索对 3, 5-环二鸟苷酸 (c-diGMP) 的先天反应
  • 批准号:
    8176709
  • 财政年份:
    2011
  • 资助金额:
    $ 23.62万
  • 项目类别:
IFN-Is at the interface of Innate and Adapative Immunity
IFN-Is 位于先天免疫和适应性免疫的界面
  • 批准号:
    7916939
  • 财政年份:
    2009
  • 资助金额:
    $ 23.62万
  • 项目类别:
Characterization of the Innate Immune Response to Crystalline Silica
对结晶二氧化硅的先天免疫反应的表征
  • 批准号:
    7846828
  • 财政年份:
    2009
  • 资助金额:
    $ 23.62万
  • 项目类别:
IFN-Is at the interface of Innate and Adapative Immunity
IFN-Is 位于先天免疫和适应性免疫的界面
  • 批准号:
    7391145
  • 财政年份:
    2004
  • 资助金额:
    $ 23.62万
  • 项目类别:
FLUORESCENCE-ACTIVATED CELL SORTER: DIABETES
荧光激活细胞分选仪:糖尿病
  • 批准号:
    6973150
  • 财政年份:
    2004
  • 资助金额:
    $ 23.62万
  • 项目类别:
FLUORESCENCE-ACTIVATED CELL SORTER: STEM CELLS: ADULT HUMAN, ADULT MOUSE
荧光激活细胞分选仪:干细胞:成年人类、成年小鼠
  • 批准号:
    6973147
  • 财政年份:
    2004
  • 资助金额:
    $ 23.62万
  • 项目类别:
FLUORESCENCE-ACTIVATED CELL SORTER: AIDS
荧光激活细胞分选仪:艾滋病
  • 批准号:
    6973148
  • 财政年份:
    2004
  • 资助金额:
    $ 23.62万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 23.62万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了